Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
35 /100
MEDIUM RISK
Score updated Oct 27, 2026

VKTX — Viking Therapeutics, Inc. Dilution Risk Tracker

Track VKTX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track VKTX — Get alerts when the score changes →

As of October 27, 2026, Viking Therapeutics, Inc. (VKTX) has a DilutionWatch DilutionScore of 35/100, rated MEDIUM dilution risk. Viking Therapeutics, Inc. has a market capitalization of $2.87B, 116.65M shares outstanding, 418 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
65
📊 Float Risk
12
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 7%
💰 Capital Raise model 15%
• Under 12 months cash (8mo)
🔔 Track VKTX — Get forecast alerts →

Market Data

Market Cap$2.87B
Shares Outstanding116.65M
Float113.28M
Cash$125.75M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore35/100DilutionWatch score record
Shares Outstanding116.65MVerified float table or market cache
Public Float113.28MVerified float table or market cache
Market Cap$2.87BMarket data cache
Cash Runway7.7 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

VKTX SEC Filing Activity — Last 12 Months

Shares outstanding reported by VKTX on the cover page of its latest 10-K/10-Q: 116.65M as of July 15, 2026.

DilutionWatch recorded 4 registration or prospectus documents for VKTX (the filings through which shares are offered) in the last 12 months. Full filing list on SEC EDGAR →

FormWhat it isFilingsMost recent
424B5prospectus supplement (ATM / shelf takedown)4Sep 24, 2026
8-Kcurrent report (material event)3Sep 28, 2026
10-Qquarterly report1Jul 29, 2026
4insider transaction5Jul 29, 2026
3initial insider ownership3Sep 23, 2026

Institutional Holdings

QoQ: ↑ 17.2% shares (2026Q1 vs prior)
418 institutional holders · 99.64M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 10.03M shares
#2 MORGAN STANLEY 9.82M shares
#3 BlackRock, Inc. 6.88M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest25.54M
Days to Cover4.4
% of Float22.5%
FINRA data as of Oct 15, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2018-03-07
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual VKTX Dilution Snapshot

Viking Therapeutics, Inc. (VKTX) has a DilutionScore of 35/100, rated Medium dilution risk. Score date: October 27, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

VKTX's DilutionScore has held steady at 35/100 (Medium risk) for 89 consecutive days across the tracked period.

Period Score Risk Level Duration
Jul 30 – Oct 27, 202635/100MEDIUM89 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

VKTX shares outstanding have decreased 0.0% from 115.89M (May 2026) to 115.89M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 04, 2026115.89M113.28M▲ 0.18%
May 03, 2026115.89M113.07M▲ 0.29%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track VKTX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment VKTX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking VKTX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,566+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for VKTX
VKTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.